izpis_h1_title_alt

Molecular and phylogenetic characterization of novel papillomaviruses isolated from oral and anogenital neoplasms of Japanese macaques (Macaca fuscata)
ID Skubic, Lucijan (Avtor), ID Hošnjak, Lea (Avtor), ID Staheli, Jeannette P. (Avtor), ID Dyen, Michael R. (Avtor), ID Ducore, Rebecca M. (Avtor), ID Colgin, Lois M. A. (Avtor), ID Lewis, Anne D. (Avtor), ID Poljak, Mario (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (2,38 MB)
MD5: 9C85DEE179054F8568C0DE78B2064B3B
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/1999-4915/13/4/630 Povezava se odpre v novem oknu

Izvleček
Papillomaviruses (PVs) are a diverse group of host species-specific DNA viruses, etiologically linked with various benign and malignant neoplasms of cutaneous and mucosal epithelia. Here, we describe the detection and characterization of the first two PVs naturally infecting Japanese macaques (Macaca fuscata), including the determination of their etiological association(s) with the development of original neoplasms. The molecular and phylogenetic analyses were performed on complete genome sequences of Macaca fuscata PV types 1 (MfuPV1) and 2 (MfuPV2), which were completely sequenced in samples of a malignant oral tumor and benign anogenital neoplasm of Japanese macaques, respectively. Subsequently, two type-specific quantitative real-time PCRs were developed to estimate viral loads of MfuPV1 and MfuPV2 and to evaluate their etiological roles. The in silico molecular analyses revealed that both viral genomes encode characteristic PV proteins with conserved functional domains and have a non-coding genomic region with regulatory sequences to regulate and complete the viral life cycle. However, additional experimental evidence is needed to finally confirm the presence and biological functionality of the molecular features of both novel PVs. While MfuPV1, together with PVs identified in other macaques, is classified into the Alphapapillomavirus (Alpha-PV) species 12, MfuPV2 is most likely a representative of the novel viral species within the Alpha-PV genus. Their relatively high viral loads suggest that both PVs are etiologically linked with the development of the original neoplasms.

Jezik:Angleški jezik
Ključne besede:papillomavirus, Macaca fuscata, molecular analysis, Alphapapillomavirus, phylogenetic analysis, viral load
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2021
Št. strani:19 str.
Številčenje:Vol. 13, iss. 4, art. 630
PID:20.500.12556/RUL-135194 Povezava se odpre v novem oknu
UDK:616.9
ISSN pri članku:1999-4915
DOI:10.3390/v13040630 Povezava se odpre v novem oknu
COBISS.SI-ID:58799107 Povezava se odpre v novem oknu
Datum objave v RUL:28.02.2022
Število ogledov:26719
Število prenosov:98
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Viruses
Skrajšan naslov:Viruses
Založnik:MDPI
ISSN:1999-4915
COBISS.SI-ID:517597977 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:07.04.2021

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:papiloma virus, Macaca fuscata, molekularna analiza

Projekti

Financer:Drugi - Drug financer ali več financerjev
Program financ.:University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P3-0083
Naslov:Odnosi parazitskega obstajanja

Financer:Drugi - Drug financer ali več financerjev
Program financ.:National Center for Research Resources
Številka projekta:R24 RR021346

Financer:Drugi - Drug financer ali več financerjev
Program financ.:National Center for Research Resources
Številka projekta:P51 RR00166

Financer:Drugi - Drug financer ali več financerjev
Program financ.:National Institute of Allergy and Infectious Diseases
Številka projekta:1R01AI111303

Financer:NIH - National Institutes of Health
Številka projekta:P51OD011092

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj